Skip to Content
MilliporeSigma
All Photos(1)

Documents

SAB1411757

Sigma-Aldrich

Anti-VEGFC antibody produced in mouse

purified immunoglobulin, buffered aqueous solution

Synonym(s):

Flt4-L, VRP

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12352203
NACRES:
NA.41

biological source

mouse

conjugate

unconjugated

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

polyclonal

form

buffered aqueous solution

mol wt

antigen 46.09 kDa

species reactivity

human

technique(s)

western blot: 1 μg/mL

NCBI accession no.

UniProt accession no.

shipped in

dry ice

storage temp.

−20°C

target post-translational modification

unmodified

Gene Information

human ... VEGFC(7424)

General description

The protein encoded by this gene is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family, is active in angiogenesis and endothelial cell growth, and can also affect the permeability of blood vessels. This secreted protein undergoes a complex proteolytic maturation, generating multiple processed forms which bind and activate VEGFR-3 receptors. Only the fully processed form can bind and activate VEGFR-2 receptors. This protein is structurally and functionally similar to vascular endothelial growth factor D. (provided by RefSeq)
The vascular endothelial growth factor-C (VEGF-C) gene with seven exons is mapped to human chromosome 4q34.3. It is a member of the VEGF family of structurally related proteins. Members of the family contain a common VEGF homology domain. This domain forms the core region and contains a cystine knot motif with eight invariant cysteine residues. In adults, VEGF-C is mainly expressed in heart, placenta, ovary, small intestine and the thyroid gland, whereas in embryonic tissue, it is expressed in the perimetanephric, axillary and jugular areas.

Immunogen

VEGFC (ABM85407.1, 1 a.a. ~ 419 a.a) full-length human protein.

Sequence
MHLLGFFSVACSLLAAALLPGPREAPAAAAAFESGLDLSDAEPDAGEATAYASKDLEEQLRSVSSVDELMTVLYPEYWKMYKCQLRKGGWQHNREQANLNSRTEETIKFAAAHYNTEILKSIDNEWRKTQCMPREVCIDVGKEFGVATNTFFKPPCVSVYRCGGCCNSEGLQCMNTSTSYLSKTLFEITVPLSQGPKPVTISFANHTSCRCMSKLDVYRQVHSIIRRSLPATLPQCQAANKTCPTNYMWNNHICRCLAQEDFMFSSDAGDDSTDGFHDICGPNKELDEETCQCVCRAGLRPASCGPHKELDRNSCQCVCKNKLFPSQCGANREFDENTCQCVCKRTCPRNQPLNPGKCACECTESPQKCLLKGKKFHHQTCSCYRRPCTNRQKACEPGFSYSEEVCRCVPSYWKRPQMS

Biochem/physiol Actions

VEGF-C (vascular endothelial growth factor-C) has a role in lymphangiogenesis. It functions through the VEGF receptor-3 (VEGFR-3). Experimental studies have shown that VEGF-C is required for lymphatic endothelial cells to form sprouting capillaries. VEGF-C expression has been observed in breast cancer, prostatic cancer, gastric cancer, colon cancer and lung cancer.

Physical form

Solution in phosphate buffered saline, pH 7.4

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class

10 - Combustible liquids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Vascular Endothelial Growth Factor and Angiogenesis
Hoeben A
Pharmacological Reviews, 56, 549-580 (2004)
Overexpression of vascular endothelial growth factor C increases growth and alters the metastatic pattern of orthotopic PC-3 prostate tumors.
Tuomela J, et al.
BMC Cancer (2009)
The effect of vascular endothelial growth factor in the progression of bladder cancer and diabetic retinopathy
Aldebasi YH
International Journal of Clinical and Experimental Medicine, 6, 239-251 (2013)
Induced lymphatic sinus hyperplasia in sentinel lymph nodes by VEGF-C as the earliest premetastatic indicator.
Liersch R
International Journal of Oncology, 41, 2073-2078 (2012)
Hui Gong et al.
Cellular and molecular life sciences : CMLS, 81(1), 39-39 (2024-01-12)
Colorectal cancer (CRC) is characterized by a complex tumor inflammatory microenvironment, while angiogenesis and immunosuppression frequently occur concomitantly. However, the exact mechanism that controls angiogenesis and immunosuppression in CRC microenvironment remains unclear. Herein, we found that expression levels of lipid

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service